Treating Opioid Use Disorder in General Practice - Diagnosis, Harm Reduction, and Medications | NEJM

Поделиться
HTML-код
  • Опубликовано: 29 сен 2024
  • In this Double Take video from the New England Journal of Medicine and NEJM
    Knowledge+, L.J. Punch (the T St. Louis, a harm-reduction program), Sarah
    Bagley (Boston Medical Center), Jennifer Foreman (Randolph Health Medical
    Group), and Scott Hadland (Massachusetts General Hospital for Children) review
    how primary care providers can best care for patients with opioid use disorder.
    They guide clinicians on how to diagnose the disorder, build trust with patients,
    offer counseling on harm reduction, and use medications to treat addiction and
    withdrawal symptoms. They also emphasize the importance of reducing stigma
    to improve therapeutic alliances with this patient population.
    To learn more about the latest practices for assessing and managing acute
    and chronic pain, current guidelines for the appropriate use of opioids for pain
    management, and evidence-based strategies for recognizing and treating opioid
    use disorder, participate in a free NEJM Knowledge+ Pain Management and
    Opioids program, available at knowledgeplusoffers .nejm
    .org/
    oud
    -double
    -take/ .
    For further reading on stigma reduction, review the following articles: Stigma
    Reduction to Combat the Addiction Crisis - Developing an Evidence Base
    (McGinty and Barry, in the April 2, 2020, issue; www.nejm.org/d... ), and Stigma as a Fundamental
    Hindrance to the United States Opioid Overdose Crisis Response (Tsai et al., in
    the November 26, 2019, issue of PLOS Medicine; journals.plos.... ).
    For further reading on alternative dosing of buprenorphine and naloxone,
    review the following articles: Low -Dose Initiation of Buprenorphine in
    Hospitalized Patients on Full Agonist Opioid Therapy: A Retrospective
    Observational Study (Schult et al, in the November 12, 2023, issue of the Journal
    of Addiction Medicine; journals.lww.c... ), and Microinduction of Buprenorphine/Naloxone:
    A Review
    of the Literature (Ahmed et al., in the December 30, 2020, issue of the American
    Journal on Addictions; onlinelibrary.... ).
    The New England Journal of Medicine is the world’s leading general medical journal. Continuously published for over 200 years, the Journal publishes
    peer-reviewed research along with interactive clinical content for physicians,
    educators, and the global medical community at NEJM.org. NEJM
    Knowledge+ is a unique adaptive learning platform with products designed to
    help clinicians meet certification requirements, prepare for board exams, and
    incorporate lifelong learning into their schedules more easily.
    #opioidcrisis #opioids #addiction #substanceusedisorder #painmanagement

Комментарии • 2